Overview

Clinical Trial of Efficacy and Safety of ММН-407 in Acute Respiratory Viral Infection

Status:
Completed
Trial end date:
2020-04-09
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of ММН-407 in treatment of acute respiratory viral infection (ARVI).
Phase:
Phase 3
Details
Lead Sponsor:
Materia Medica Holding